1. Home
  2. SWTX vs CARG Comparison

SWTX vs CARG Comparison

Compare SWTX & CARG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SWTX
  • CARG
  • Stock Information
  • Founded
  • SWTX 2017
  • CARG 2005
  • Country
  • SWTX United States
  • CARG United States
  • Employees
  • SWTX N/A
  • CARG N/A
  • Industry
  • SWTX Biotechnology: Pharmaceutical Preparations
  • CARG EDP Services
  • Sector
  • SWTX Health Care
  • CARG Technology
  • Exchange
  • SWTX Nasdaq
  • CARG Nasdaq
  • Market Cap
  • SWTX 3.5B
  • CARG 3.2B
  • IPO Year
  • SWTX 2019
  • CARG 2017
  • Fundamental
  • Price
  • SWTX $47.00
  • CARG $33.18
  • Analyst Decision
  • SWTX Buy
  • CARG Buy
  • Analyst Count
  • SWTX 7
  • CARG 11
  • Target Price
  • SWTX $56.86
  • CARG $36.95
  • AVG Volume (30 Days)
  • SWTX 4.5M
  • CARG 822.3K
  • Earning Date
  • SWTX 08-06-2025
  • CARG 08-07-2025
  • Dividend Yield
  • SWTX N/A
  • CARG N/A
  • EPS Growth
  • SWTX N/A
  • CARG 27.38
  • EPS
  • SWTX N/A
  • CARG 0.36
  • Revenue
  • SWTX $219,670,000.00
  • CARG $903,746,000.00
  • Revenue This Year
  • SWTX $74.36
  • CARG $7.60
  • Revenue Next Year
  • SWTX $75.63
  • CARG $8.07
  • P/E Ratio
  • SWTX N/A
  • CARG $91.94
  • Revenue Growth
  • SWTX 730.42
  • CARG 0.63
  • 52 Week Low
  • SWTX $28.21
  • CARG $21.65
  • 52 Week High
  • SWTX $62.00
  • CARG $41.33
  • Technical
  • Relative Strength Index (RSI)
  • SWTX 63.86
  • CARG 60.17
  • Support Level
  • SWTX $46.93
  • CARG $32.26
  • Resistance Level
  • SWTX $47.02
  • CARG $33.51
  • Average True Range (ATR)
  • SWTX 0.08
  • CARG 0.77
  • MACD
  • SWTX -0.06
  • CARG 0.06
  • Stochastic Oscillator
  • SWTX 90.32
  • CARG 90.97

About SWTX SpringWorks Therapeutics Inc.

SpringWorks Therapeutics Inc is a clinical-stage biopharmaceutical company applying a precision medicine approach to acquiring, developing, and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer. The company has a differentiated portfolio of small molecule targeted oncology product candidates and is advancing two potentially registrational clinical trials in rare tumor types, as well as several other programs addressing prevalent, genetically defined cancers. OGSIVEO, the first commercial product, is a novel, oral, selective gamma-secretase inhibitor. GOMEKLI, the second commercial product, is an oral, small molecule mitogen-activated protein kinase, or MEK, inhibitor.

About CARG CarGurus Inc.

CarGurus Inc is a company that acts as an online automotive marketplace connecting buyers and sellers of new and used cars. The company provides three types of marketplace Listing products, Restricted Listings, and Enhanced or Featured Listings, through which it offers real-time and historical data analyzing the connections and pricing analysis. The listing platforms offer auto manufacturers and others to buy advertising on the company's site and target consumers based on the make, model, and zip code of the cars. The company operates through two segments, namely U.S. Marketplace and Digital Wholesale. It generates maximum revenue from the U.S. Marketplace segment. Geographically, the company derives its key revenue from the United States and the rest from international markets.

Share on Social Networks: